MXene‐Powered Terahertz Metamaterials as a Real‐Time Biosensing Platform for In Vivo Thrombus Monitoring (Adv. Mater. 2/2026)

Biosensing Platform for In Vivo Thrombus Monitoring A novel biosensing platform is developed using an MXene-powered terahertz metamaterial, which substantially increases the early thrombus detection ability by utilizing the highly sensitive terahertz response from the interfacial charge transfer between MXene and thrombus. This platform demonstrates the potential for tailoring clinical anticoagulation strategies for individual patients to reduce the current high risk of thrombus complications for cardiovascular diseases. More details can be found in the Research Article by Ke Yang, Xu Xiao, Min Hu, Xiang Yang, and co-workers (DOI: 10.1002/adma.202507063).